The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ranitidine 150mg/10ml Oral Solution



LTT Pharma LimitedPPA1562/130/001

Main Information

Trade NameRanitidine 150mg/10ml Oral Solution
Active SubstancesRANITIDINE HYDROCHLORIDE
Dosage FormOral solution
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/130/001

Group Information

ATC CodeA02BA H2-receptor antagonists
A02BA02 ranitidine

Status

License statusWithdrawn
Withdrawn Date08/02/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0087-144-054
Interchangeable List DocumentPDF of Interchangeable List
« Back